Bradford K. Amman - 23 Dec 2022 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Financial Officer
Signature
/s/ Bradford K. Amman
Issuer symbol
VVOS
Transactions as of
23 Dec 2022
Net transactions value
+$96,000
Form type
4
Filing time
28 Dec 2022, 20:45:24 UTC
Previous filing
28 Feb 2022
Next filing
28 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $96,000 +200,000 +67% $0.4800 500,001 23 Dec 2022 Common Stock 500,001 $0.4800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 200,000 stock options granted on December 23, 2022. One-fifth vests annually on each anniversary date through December 23, 2026.